Our Research
Montefiore Einstein Center for Transplantation is at the forefront of solid organ transplant research, led by a multidisciplinary team of scientists actively conducting studies in collaboration with specialists across the world. The Center’s innovations in clinical, translational and basic research continue to surface new insights in the field of transplantation, enabling us to offer innovative treatments and access to advanced clinical research trials that lead to improved outcomes and overall quality of life.
Liver Research
We study a diverse cross-section of clinical research topics related to liver transplant, including liver cancer, acute liver failure, hepatitis, fatty liver disease, and cellular/stem transplants.
Marion Bessin Liver Research Center
The Marion Bessin Liver Research Center focuses on studying the fundamental mechanisms of normal liver function; alterations in these functions resulting from metabolic disorders, genetic diseases, acute and chronic liver injury, hepatitis virus infection, hepatic fibrosis and liver cancer; and ways to overcome these abnormalities using advanced methods of genetic engineering, gene therapy and liver cell transplantation.
Kidney Transplant Research
We study a diverse cross-section of clinical research topics related to kidney transplantation, including sensitized patients, immunologic risk assessment, and many more. Our lab-based research is supported by grants from National Institutes of Health (NIH), Radiation Oncology Institute (ROI) and many others. We continue to uncover new insights, with a focus on microarray technology and molecular diagnostic methods.
Clinical Trials
Our kidney and pancreatic transplantation teams actively conduct numerous multicenter trials that continue to uncover life-changing insights, including a recently published discovery showing that transplantation of Hepatitis C-positive kidneys into uninfected recipients creates an opportunity to increase organ access. Additional clinical trials include kidney transplant complications, Idiopathic Nephrotic Syndrome (NS), and diagnostic molecular features in kidney allograft biopsies.
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
-
Start Date
July 14, 2021
-
Conditions
Transplant, Complication, Rejection
TruGraf® Long-term Clinical Outcomes Study
-
Start Date
September 9, 2020
-
Conditions
Kidney Transplant Rejection
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection (SPARO)
-
Start Date
September 14, 2018
-
Conditions
Transplant Rejection, Allograft Rejection , Complications
News & Publications